Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY48.70 CNY
Change Today 0.00 / 0.00%
Volume 0.0
300142 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 06/12/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for walvax biotechnology co-a (300142)

Year over year, Walvax Biotechnology Co.,Ltd has been able to grow their bottom line from CNY47.9M CNY to CNY143.4M CNY primarily through revenue growth (CNY571.7M CNY to CNY715.3M CNY). For while the costs associated with cost of goods, SGA and income tax all increased as a percentage of sales, the growth in top line revenues contributed enough to still see net income improve.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2011
Restated
CNY
Dec 31
2012
Restated
CNY
Dec 31
2013
Restated
CNY
Dec 31
2014
CNY
4 Year
Trend
Revenues473.8537.6571.7715.3
Other Revenues0.1--11.43.7
TOTAL REVENUES473.8537.6583.1719.0
Cost of Goods Sold50.872.9169.6420.0
GROSS PROFIT423.0464.7413.5299.0
Selling General & Admin Expenses, Total220.0236.0355.2553.6
Other Operating Expenses5.26.08.512.3
OTHER OPERATING EXPENSES, TOTAL225.2242.0363.7565.9
OPERATING INCOME197.8222.749.8-266.9
Interest Expense-3.2-10.0-70.2-170.6
Interest and Investment Income43.541.224.3578.9
NET INTEREST EXPENSE40.431.2-45.9408.2
Currency Exchange Gains (Loss)------0.0
Other Non-Operating Income (Expenses)-0.1-0.4-0.4-2.2
EBT, EXCLUDING UNUSUAL ITEMS238.1253.53.5139.2
Gain (Loss) on Sale of Assets-3.60.00.0-0.6
Other Unusual Items, Total11.413.96.8-0.6
Other Unusual Items11.513.96.810.4
EBT, INCLUDING UNUSUAL ITEMS245.9267.510.3138.0
Income Tax Expense38.442.15.441.3
Minority Interest in Earnings--7.443.046.7
Earnings from Continuing Operations207.5225.44.996.7
NET INCOME207.5232.847.9143.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS207.5232.847.9143.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS207.5232.847.9143.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300142:CH CNY48.70 CNY 0.00

300142 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300142.
View Industry Companies
 

Industry Analysis

300142

Industry Average

Valuation 300142 Industry Range
Price/Earnings 100.0x
Price/Sales 31.7x
Price/Book 7.9x
Price/Cash Flow 155.3x
TEV/Sales 28.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WALVAX BIOTECHNOLOGY CO-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.